findmyKOL

Richard Pratley, MD

Enriched profile

Samuel E. Crockett Chair in Diabetes Research; Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute; Medical Director, AdventHealth Diabetes Institute · AdventHealth Diabetes Institute

ORCIDNone on fileNPI
Region🇺🇸 Orlando, FL · Southeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusType 1 Diabetes+2
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding2019–2026Why? →

Richard Pratley is Samuel E. Crockett Chair in Diabetes Research; Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute; Medical Director, AdventHealth Diabetes Institute at AdventHealth Diabetes Institute. ClinicalTrials.gov lists 20 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Richard E. Pratley, MD, is Samuel E. Crockett Chair in Diabetes Research at AdventHealth Diabetes Institute / AdventHealth Translational Research Institute, Orlando, FL. The public record shows 38 publications with 2,962 citations (h-index 9), centered on Type 1 Diabetes, Type 2 Diabetes, Obesity. It also documents an investigator role on 20 registered clinical trials, industry payments reported by 20 companies, 6 NIH-funded awards (2019–2026).

  • Top research focus: Type 1 Diabetes
  • 20 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 1 Diabetes6 trialsType 2 Diabetes5 trialsObesity3 trialsPancreatitis2 trialsPancreatic Cancer1 trialHeart Failure1 trialCOVID-191 trialInsulin Resistance1 trialHypertension1 trialOverweight1 trial

Research focus

OpenAlex concept fingerprint
Type 1 DiabetesType 2 DiabetesObesity

Drugs & molecules

across trials, industry payments and publications
Ozempicgeneric · SemaglutideClinical trialsIndustry payments60PublicationsZepboundgeneric · TirzepatideClinical trialsIndustry payments46PublicationsKorlymgeneric · MifepristoneClinical trialsIndustry payments43Publications

Works with

trial sponsors and companies reporting payments
Novo Nordisk IncClinical trialsIndustry payments68Lilly USA, LLCClinical trialsIndustry payments59Novo Nordisk ASClinical trialsIndustry payments52

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
20clinical trials

Investigator role on registered studies.

View trials
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
6NIH grants · 2019–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 20 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    70%
    GLP-1 receptor agonist21.8%
    Ozempic61%Mounjaro25%Trulicity14%
    Part D<11 patients
    Insulin Analog17%
    Tresiba Flextouch U-10051%Humalog32%Lantus Solostar18%
    Part D<11 patients
  • Cardiovascular

    18.5%
    Statin12%
    Atorvastatin Calcium48%Simvastatin32%Rosuvastatin Calcium21%
    Part D<11 patients
    Calcium channel blocker3.8%
    Amlodipine Besylate100%
    Part D<11 patients
  • Hormonal (systemic)

    11.5%
    l-Thyroxine11.5%
    Levothyroxine Sodium65%Synthroid35%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

6 NIH research awards on record, funded 20192026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/richard-pratley-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/richard-pratley-378b719a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Richard-Pratley

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    beckershospitalreview.com/podcasts/podcasts-beckers-hospital-review/-dr-richard-pratley-medical-director-at-adventhealth-diabetes-institute-132881937

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beckershospitalreview.com
  • YouTube

    healio.com/news/endocrinology/20220607/video-richard-pratley-md-spotlights-most-exciting-topics-at-ada-meeting

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com
  • X / Twitter

    Twitter/X handle @rpratleymd

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.